Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases

US8268864B2 · kind B2 · utility

Assignee

• MEDA PHARMA GMBH & CO. KG · DE

Inventors

• Beatrix Fyrnys · Zwingenberg, DE
• Torsten Hoffmann · Weil am Rhein, DE
• Mario Weingart · Dresden, DE
• Istvan Szelenyi · Arnstorf, DE
• Peter Jurgen Cnota · Bad Homburg vor der Höhe, DE
• Ullrich Munzel · Mellrichstadt, DE
• Ursula Petzold · Emmelshausen, DE
• Joachim Maus · Mühlheim, DE

Key dates

• Filing date: Mar 16, 2006
• Grant date: Sep 18, 2012
• Expiry date: Apr 21, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Pharmaceutical compositions comprising an anticholinergic and at least one leukotriene inhibitor for treatment of respiratory diseases, including allergic rhinitis, bronchial asthma, COPD and common cold, and methods of treatment.